BlackBerry provides wireless devices and solutions for the worldwide mobile communications market. It is widely known for the development of the Blackberry smartphone.   It offers the BlackBerry wireless communications platform solution, which includes the commpression and security infrastructure services enabling BlackBerry hand-held wireless devices to send and receive wireless messages and data. It is engaged in the sale of BlackBerry hand-held devices and the provision of data communication.   Its portfolio of products and solutions includes the BlackBerry wireless solution, the BlackBerry Wireless Hand-held product line, the BlackBerry PlayBook tablet, software development tools, and other software and hardware. It also provides QNX software for embedded systems market and BBM, which is known as an instant mobile to mobile private messaging service. BlackBerry also carries expertise in allowing third party commercial and enterprise software developers to build and deploy custom applications to run on BlackBerry smartphones. In addition, it provides its users with the BlackBerry Messenger Social Apps Platform, push, payments, advertising, location, maps, analytics, and Scoreloop services as well as repair and maintenance services.   BlackBerry is engaged in the sales of its solutions through wireless communication carriers and third party distribution channels.

Blackberry

Blackstone Group is a private equity firm that invests in private equity, real estate, public debt, equity, non-investment grade credit, real assets, and secondary funds.

Blackstone Group

​ ​​​​​​​​​​​​​​​​​​​​​​The Kuwait Investment Authority (KIA) is the oldest sovereign wealth fund in the world. KIA traces its roots to the Kuwait Investment Board, which was established in 1953, eight years before Kuwait's independence in 1961. In 1982, KIA was created by Law No. 47 as an autonomous governmental body responsible for the management of the assets of the country.​

Kuwait Investment Authority

Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options.   There are hundreds of clinical trials at major medical centers evaluating compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma (MM), myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), pancreatic cancer, non-small lung cancer and melanoma.   In addition, several compounds are being evaluated as therapies for serious inflammatory diseases such as psoriasis and psoriatic arthritis.

Celgene

Verizon Ventures seeks and invests in promising entrepreneurial companies who are tackling some of today’s biggest technological challenges for Verizon's consumer and enterprise customers.  Over the last decade Verizon Ventures has invested in more than forty companies covering a range of industries, technologies and market segments. Verizon Ventures offers support to its portfolio companies with technology and product development, market planning and sales, and access to the networks and platforms of Verizon Communications.  Combining the power of experienced investment professionals with a focused venture development team, Verizon Ventures connects innovators with strategic and financial resources that advance their businesses.

Verizon Ventures

NantHealth

NantOmics develops cloud-based molecular profiling tools that help guide cancer patients. It is a molecular diagnostics company, develops molecular profiling solutions that identify personalized treatment options for cancer patients and their providers at the point of care. It offers GPS Cancer test that provides a molecular profile of patient’s cancer to inform personalized treatment strategies to oncologists and OncoPlexDx Targeted Proteomic panel that provides quantitative protein biomarker information for multiple clinically relevant proteins yielding insights into the biology driving the growth of the patient’s cancer.  Patrick Soon-Shiong founded NantOmics in 2012, with its headquarters in Culver City, California. NantOmics operates as a subsidiary of NantWorks.

A leader in advanced speech and linguistic interfaces, Fluential has devoted more than 85 man-years of research to developing and improving interactive voice technologies for the military, healthcare and digital health industries. Recognizing that speech is the next essential function of mobile and consumer devices, Fluential focuses on optimizing the voice experience with multimodal interactions that both simplify and advance consumers’ lives.

NantHealth is a healthcare company providing an evidence-based platform for healthcare diagnostics. It is a transformational healthcare company converging science and technology through an integrated clinical platform that’s empowering physicians, patients, payers, and researchers to transcend the traditional barriers of today’s healthcare system. The company's solutions are advancing diagnostics to better identify and target specific disease characteristics; transforming clinical delivery with clinical data and promoting wellness for a healthier, happier world. They are building an integrated, evidence-based, genomically-informed, personalized approach to the delivery of care and the development of next-generation healthcare solutions.

NantHealth is a company that develops software and devices for healthcare providers and payers, operating at the intersection of precision medicine and value-based care. Their technology solutions aim to enable integrated healthcare delivery networks, promote efficiency, personalized treatment, and collaboration across the healthcare ecosystem. NantHealth's core offerings include software products that assist healthcare providers in assessing patients' conditions, matching them with evidence-based treatments, and ensuring the recommended protocols align with the patients' insurance coverage. Their business model revolves around providing innovative software solutions to streamline healthcare delivery and enhance patient outcomes.

Helping NantHealth Align Their Product Marketing to Their Audiences

Simplifying healthcare administration with intuitive tech tools

Hospital Management

NantHealth, Inc Appoints Scott Maratea as Chief Revenue Officer

Baxter International

To connect Baxter's Prismaflex system to a hospital electronic medical record (EMR).

NantHealth is a company that develops software and devices for healthcare providers and payers, operating at the intersection of precision medicine and value-based care. Their technology solutions aim to enable integrated healthcare delivery networks, promote efficiency, personalized treatment, and collaboration across the healthcare ecosystem. NantHealth's core offerings include software products that assist healthcare providers in assessing patients' conditions, matching them with evidence-based treatments, and ensuring the recommended protocols align with the patients' insurance coverage. Their business model revolves around providing innovative software solutions to streamline healthcare delivery and enhance patient outcomes.

Modernizing Medicine is a healthcare technology company that specializes in developing cloud-based electronic health record (EHR) systems and solutions tailored for specific medical specialties. Their flagship products, EMA and gGastro EHR, are designed to streamline clinical workflows and documentation processes, saving time for healthcare providers. These intuitive platforms incorporate built-in medical knowledge and can adapt to individual practice preferences.
Beyond EHRs, Modernizing Medicine offers an integrated suite of products and services, including practice management, revenue cycle management, endoscopy report writing, analytics, and advisory services. Their solutions aim to address the challenges of value-based care, such as population health management, quality measure reporting, and optimizing reimbursements.
Modernizing Medicine's innovative EHR architecture emphasizes speed, convenience, and adaptability, enabling doctors to complete exams efficiently. The systems can generate notes, suggest codes, and automate billing processes, reducing administrative burdens.
In November 2022, Modernizing Medicine agreed to pay USD 45 million to resolve allegations of accepting and paying illegal kickbacks, as well as causing users to report inaccurate information for federal incentive payments. The settlement addressed three marketing programs alleged to have violated the False Claims Act and the Anti-Kickback Statute.

Modernizing Medicine

Kyruus Health is a leading provider of care access solutions that connect patients with the right healthcare providers. The company's platform integrates comprehensive provider data, enabling informed decisions and seamless access to care across various touchpoints. Kyruus Health's offerings include provider search and scheduling tools, cost transparency solutions, and data management capabilities.
Kyruus Health's technology facilitates provider matching, appointment scheduling, and digital patient intake processes. The platform enhances the overall patient experience by streamlining access to care and ensuring transparency regarding provider expertise, availability, and costs. Additionally, Kyruus Health's solutions empower healthcare organizations, such as hospitals, medical groups, and health plans, to optimize provider utilization and comply with industry mandates.
Through strategic acquisitions and partnerships, Kyruus Health has expanded its network to encompass over 425,000 providers across more than 1,000 hospitals and 500 medical groups. As of 2023, the company served over 90 million health plan members from 100 different health plan brands, solidifying its position as a leading care access platform.
Key customers and partnerships
In July 2024, Kyruus Health announced a strategic partnership with XO Health, an innovative healthcare services organization designed for self-insured employers. This collaboration aimed to enhance XO Health's digital member experience by integrating Kyruus Health's provider search and cost transparency tools, ultimately creating a seamless healthcare journey for members, providers, and payers.
Furthermore, in May 2024, Kyruus Health expanded its national provider network by integrating virtual behavioral health providers, demonstrating its commitment to improving access to mental health services. This expansion added over 30,000 virtual behavioral health providers to the Kyruus Network, enabling health plans, hospitals, and medical groups to seamlessly integrate these providers into their online directories and address access gaps.
Kyruus Health also partnered with WellHive and V3 Gate to support the Veterans Health Administration (VHA), aiming to improve care for all Veterans by accelerating access to care through centralized appointment management across VHA sites.

Kyruus

AKASA is a healthcare technology company that leverages advanced generative AI and machine learning models to address administrative inefficiencies and financial challenges in the revenue cycle management (RCM) process. Their AI solutions are specifically trained on vast amounts of clinical and financial data to comprehend the nuances of the healthcare industry.
AKASA's platform is powered by large language models and generative AI capabilities akin to ChatGPT, but optimized and tailored for the healthcare domain. Their AI understands clinical context, grasps the intricate details of health systems, and is designed to integrate directly into staff workflows, enabling automation of routine tasks and improving operational efficiencies.
The company takes an "expert-in-the-loop" approach called Unified Automation, which combines machine learning with human expertise. This allows their technology to adapt to the dynamic nature of revenue cycle operations while benefiting from the judgement of AKASA's in-house team of RCM veterans with an average of over 15 years of industry experience.
AKASA's solutions aim to reduce the substantial administrative waste associated with billing and insurance communication failures, estimated at over USD 500 billion annually in the USD 4 trillion healthcare industry. By automating comprehensive and complex tasks, AKASA enables healthcare providers to reallocate staff toward patient-facing activities and enhance care delivery.

AKASA

XSOLIS is an AI technology company that offers a platform and solutions to create a more efficient healthcare system by facilitating improved communication and alignment between healthcare providers and payers. The company's flagship product, CORTEX, is an AI-driven platform that utilizes real-time predictive analytics to continuously assign an objective medical necessity score and assess the anticipated level of care for every patient. This technology aims to eliminate waste by leveraging data science, automation, transparency, and objective insights to ensure appropriate care settings.
XSOLIS's solutions streamline patient status communications, enabling providers and payers to align on medical necessity, length of stay timelines, and appropriate care levels. The platform's AI capabilities enable the creation of live clinical profiles for each patient, recognizing patterns to generate predictive analytics for determining the most suitable care setting. CORTEX reduces the administrative burden of case reviews through its proprietary Care Level Score (CLS), allowing teams to prioritize discharge planning tasks and driving optimal workflows.
By August 2022, XSOLIS achieved a three-year revenue growth of 388%, ranking No. 1795 on the 2022 Inc. 5000 list of America's fastest-growing private companies. The company reported 111% growth in its payer network and a 44% increase in hospital partnerships in the same year.

XSOLIS

Suki AI is a healthcare technology company that develops an AI-powered voice assistant, Suki Assistant, designed to help clinicians complete administrative tasks efficiently. The Suki Assistant utilizes natural language processing and generative AI to transcribe conversations between clinicians and patients into clinical notes, populating electronic health records (EHRs) with relevant data. By automating documentation, the company aims to reduce the time clinicians spend on paperwork, claiming to shrink it by as much as 72% in family medicine settings.
Suki Assistant offers multiple modes, including ambient note generation, dictation, and voice commands. The ambient mode leverages generative AI to listen to clinician-patient interactions and auto-generate clinical notes in real-time without human intervention. Clinicians can accept, reject, or edit the AI-generated content to ensure accuracy. In addition to documentation, Suki Assistant can retrieve patient information, such as medication lists and allergies, from EHRs and provide diagnosis code recommendations.
Suki Assistant is deeply integrated with major EHR systems, including Epic, Cerner, athenahealth, Elation, and Meditech, enabling bidirectional synchronization of notes and codes. The company expanded its capabilities to support inpatient care settings in October 2023, making it the first AI-powered voice solution tailored for clinicians in hospitals. Suki Assistant operates across various platforms, including iOS, Android, web, Windows, Mac, and as a Chrome extension.
In October 2023, Suki announced the acquisition of an undisclosed company to enhance its personalization features, allowing the assistant to adapt to individual user preferences and existing workflows.

Suki

Platforms used by hospitals to manage the various aspects of patient care to improve overall efficiency, such as automating routine tasks, improving communication and coordination among healthcare providers, and enhancing patient outcomes within the hospital setting

Platforms that enable patients to actively participate in their healthcare journey by educating and engaging them, along with improving communication with healthcare providers

Platforms that help healthcare organizations analyze patient data and other performance metrics to improve decision-making and optimize resource allocation

Platforms that are designed to help hospitals and health systems manage their financial operations from patient billing and insurance claims to revenue tracking and analysis

AI-powered software solutions that are designed to help healthcare organizations streamline and automate the process of documenting patient encounters

Companies that use GenAI as a core part of their product offering for hospital management

Offers software platforms that streamline and improve hospital operations

AI/ML algorithms optimize workflows, enable predictive modeling, and analyze patient data in healthcare

Hospital Management companies use GenAI to manage and automate administrative tasks, offering a range of tech solutions designed to meet the needs of different departments and functions.

IoT medical solutions turn traditional hospitals into smart hospitals, allowing them to streamline workflows

NantHealth

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless